Statins and the risk of pancreatic cancer: A systematic review and meta-analysis of 2,797,186 patients.

Eryka Karbowska Damian ŚWieczkowski Aleksandra Gasecka Francesco Chirico Kamil Safiejko Jerzy Robert Ładny Tomasz Kopiec Milosz Jaroslaw Jaguszewski Krzysztof Jerzy Filipiak Frank W Peacock Agnieszka Szarpak

Published in: Cardiology journal (2022)

In summary, the present analysis shows that overall statins use is significantly associated with a reduction in risk of pancreatic cancer. However, these results were not confirmed for the randomized controlled trial subgroup. Further prospective studies are needed to confirm the current results.

Keyphrases

randomized controlled trial
end stage renal disease
cardiovascular disease
ejection fraction
newly diagnosed
chronic kidney disease
study protocol
peritoneal dialysis
clinical trial
type diabetes
patient reported outcomes
patient reported
double blind